Harry Cutler, a sleep apnea patient, has been awarded patent protection in the United Kingdom. The patent protects a medical device created initially to treat Mr. Cutler’s own obstructive sleep apnea (OSA) which afflicts from 12% to 25% of the population. The device also reduces or eliminates snoring, one of the primary side effects of OSA. Unlike other oral appliances, it can be used by people with loose teeth, dentures, or no teeth at all, thereby eliminating costly dental preparation. It is being marketed as the “RespireAide Sleep Apnea Solution”.

In this case, necessity was indeed the mother of invention. Underemployed at the time and without insurance, Cutler’s sleep apnea became severe. “I was falling asleep while driving to work, in the middle of the day! I had to do something,” said Cutler.

He researched the condition and began to fashion a solution mostly from items found around the house or purchased from the local hardware and sporting goods stores. “The initial device was somewhat crude, but it did help. Over the following six years, using myself as a test subject, I refined and improved the device with the goal of creating an acceptable combination of comfort and effectiveness. The resultant device bears little resemblance to the original,” he added.

Cutler decided to share the device with the public after receiving numerous requests from others afflicted with sleep apnea…and especially their family members. CPAP (Continuous Positive Airway Pressure) is considered the “gold standard” in sleep apnea treatment.

Unfortunately, since it requires wearing a facial or nasal mask and being tethered to an air pump during the night, it cannot be tolerated by 40% to 50% of those who begin using it. “Spouses complained that their partner’s CPAP machine was collecting dust in the closet and that the sleep apnea was not being treated at all. Besides the lack of treatment for OSA, the heavy snoring was also untreated, causing the afflicted partner to be banished from the spouse’s bedroom. It is like adding insult to injury,” Cutler said.

“It seemed to me that there was an opportunity in the marketplace for a simple, inexpensive, and effective alternative,” Cutler said. Overnight testing of the device in an accredited sleep lab showed significant reductions in both sleep apnea and snoring. “There is a potential to reduce OSA by up to 95% and virtually eliminate snoring, depending on the success of the user in properly adjusting the device. Because some people may not tolerate intra oral devices, or will not succeed in properly adjusting it, I decided to offer a 30 Day Money Back Guarantee.

Besides spending only 5% to 10 % of the cost of conventional treatments, a purchaser can return the device regardless of the reason,” he added. It can be used as primary treatment or as a shirt-pocket backup/traveling companion for those who have managed to acclimate themselves to CPAP. No more hassles at the airport for frequent fliers!

“The company is based in U.S. and Canada and due to the logistics involved, I would prefer to find a local entity to aid in the distribution of the product within the UK. An equity position, licensing agreement, or other acceptable arrangement would be considered. Interested parties should inquire to RespireAide@hotmail.com,” Cutler concluded.

Patents are pending in the USA, Canada, and India.The device, along with a storage case, retaining strap, cleaning brush, and an overnight/travel pouch is available at www.RespireAide.com.

Related Posts with Thumbnails

Tagged with:

Filed under: CPAPCPAP DeviceCPAP MaskCPAP TherapyDental AppliancesObstructive Sleep ApneaOral AppliancesPortable DevicesPress ReleaseSleepSleep ApneaSleep Apnea DevicesSleep Apnea EquipmentsSleep Apnea MaskSleep Apnea NewsSleep Apnea TreatmentSnoringSnoring SolutionSnoring Treatment

Like this post? Subscribe to my RSS feed and get loads more!